Bayer Takes License For Homocysteine Assay
Under the accord reached, Bayer was granted a license under the Competitive Technologies patent and will pay royalties on sales of Bayer homocysteine assays, the companies said in a joint release.
Customers who purchase Bayer homocysteine assays will be covered by the Bayer license from Competitive Technologies. Bayer customers such as...
To view the full article, register now.